< Zurück zu den aktuellen Neuigkeiten & Events

Veranstaltungen

HGF webinar: Getting your first filing right

März 2022

Veranstaltungsdatum: 23. März 2022

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right.

One of the most often asked questions of patent attorneys is: “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is especially so in the therapeutic field where wide breadth of claim is desired coupled with maximum use of the available 21 year patent term from first filing. Circumstances can nevertheless necessitate a first filing needing to be considered in a pressurised situation. Even so, strategy from the start needs to be a matter of careful consideration to avoid later problems. The CRISPR patent battle in Europe illustrates well how first filing issues can be a source of costly, unwanted problems which are avoidable.

This presentation covered the considerations required at the first filing stage to align patenting strategy with commercial strategy and minimise problems arising from both formal and content issues. The presentation covered such issues as the evidence required to get over the plausibility hurdle in relation to inventive step and sufficiency as applied to compound and therapeutic use claims, as well as formal considerations such as where to file and who should file, often especially important considerations in the case of collaborative projects involving inventors outside the UK. The presentation also dealt with how to ensure you keep priority of a first filing both legally and to maximise disclosure benefit.

Speaker

Dr Claire Irvine – Partner & Patent Attorney

Watch the webinar:

Aktuelle Neuigkeiten

Event - 11. November 2025

OIS Investor Forum - Jeffries

HGF is proud to be sponsoring the OIS Investor Forum on 18th November. One of the premier gatherings for leaders, innovators, and investors across the healthcare industry. The forum covers …

Veranstaltungsdetails

From Stripes to Supermarkets: The Court of Appeal Reaffirms the Need for Precision in Trade Mark Law

On 23 October 2025, Lord Justice Arnold delivered two landmark Court of Appeal decisions addressing trade mark registrability: Thom Browne Inc & Anor v adidas AG [2025] EWCA Civ 1340 …

Weiterlesen

Protecting Digital Health innovation in the AI revolution

As artificial intelligence (AI) continues to transform healthcare, from diagnostic imaging and drug discovery to wearable devices and clinical decision support, questions around how to protect these advancements have become …

Weiterlesen

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Weiterlesen
Event - 4. November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Veranstaltungsdetails
Event - 30. bis 31. Oktober 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Veranstaltungsdetails

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Weiterlesen

Agritech Thymes: Die Gefahr der stillschweigenden Zustimmung: Lehren aus dem Fall „Pink Lady“

Kann die Lieferung einer Pflanzensorte ohne klare und definierte Nutzungsbeschränkungen als stillschweigende Zustimmung zu ihrer Vermarktung angesehen werden? Im Mittelpunkt dieses Falls stehen die Beweise, die erforderlich sind, um „ernsthafte …

Weiterlesen